ConductScience.org, home

Paper4581906

Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis.

Perry HM. Am J Med, 1973. Cited by 336 papers, by iCite.

Cite this record

ConductScience Library. Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis. Papers, record 4581906. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4581906

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis.
PubMed
Journal
Am J Med
PubMed
Year
1973
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
336
iCite
Relative citation ratio, by iCite
14.7
iCite
Revised in PubMed
2019-06-26
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Perry HM JrH M

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Arthritis, RheumatoidMajor topic
Drug HypersensitivityMajor topic
HydralazineMajor topic
Lupus Erythematosus, SystemicMajor topic
Acetylation
Adult
Antibodies, Antinuclear
Antigen-Antibody Reactions
Blood Pressure
DNA
Diagnosis, Differential
Female
Fever
Follow-Up Studies
Humans
Hypertension
Male
Polymorphism, Genetic
Seasons
Syndrome
Time Factors

Source PubMed

Download CSV of topics

Cited by66

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 336 citations.

PMIDTitleJournalYearIn PapersSource
40632154The change in the pharmacological significance of dihydralazine (Germany) and hydralazine (USA).Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/40632154PubMed
32953340A Case of Seronegative ANA Hydralazine-Induced Lupus Presenting With Pericardial Effusion and Pleural Effusion.Cureus2020https://conductscience.org/library/papers/32953340PubMed
22454932Acetylation of procaine amide in man studied with a new gas chromatographic method.Br J Clin Pharmacol1974https://conductscience.org/library/papers/22454932PubMed
20544243Acrylamine-induced autoimmune phenomena.Clin Rheumatol2010https://conductscience.org/library/papers/20544243PubMed
18489081Procainamide, but not N-acetylprocainamide, induces protein free radical formation on myeloperoxidase: a potential mechanism of agranulocytosis.Chem Res Toxicol2008https://conductscience.org/library/papers/18489081PubMed
8535929Drug-induced "allergic hepatitis".Clin Rev Allergy Immunol1995https://conductscience.org/library/papers/8535929PubMed
8435078Effect of thiol compounds on human complement component C4.Biochem J1993https://conductscience.org/library/papers/8435078PubMed
8396914Arylamine N-acetyltransferase activity in human cultured cell lines.Biochem J1993https://conductscience.org/library/papers/8396914PubMed
7946001Adverse effects of direct-acting vasodilators.Drug Saf1994https://conductscience.org/library/papers/7946001PubMed
7516856Selecting appropriate antihypertensive drug dosages.Drugs1994https://conductscience.org/library/papers/7516856PubMed
7427242Hydrallazine-induced lupus erythematosus-like syndrome in a patient of the rapid acetylator phenotype.Br Med J1980https://conductscience.org/library/papers/7427242PubMed
7357301Hydrallazine-induced cutaneous vasculitis.Br Med J1980https://conductscience.org/library/papers/7357301PubMed
7314046Hydralazine lung.Thorax1981https://conductscience.org/library/papers/7314046PubMed
7259927Further evidence for an acetylator phenotype difference in the metabolism of hydralazine in man.Br J Clin Pharmacol1981https://conductscience.org/library/papers/7259927PubMed
7205989Acute low-dose hydralazine induced lupus syndrome (HILS).J Natl Med Assoc1981https://conductscience.org/library/papers/7205989PubMed
7202470A clinical and pharmacokinetic evaluation of tolmesoxide in hypertensive patients.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7202470PubMed
7191632Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity.Am J Hum Genet1980https://conductscience.org/library/papers/7191632PubMed
7047041Clinical pharmacokinetics of hydralazine.Clin Pharmacokinet1982https://conductscience.org/library/papers/7047041PubMed
7021123Adverse effects of antihypertensive drugs.Drugs1981https://conductscience.org/library/papers/7021123PubMed
7011656Acetylator phenotype and lupus erythematosus.Clin Pharmacokinet1981https://conductscience.org/library/papers/7011656PubMed

See all 66 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4581906

GET https://conductscience.org/api/papers/v1/4581906/cited_by?page=2